Literature DB >> 17392362

Human immunodeficiency virus type 1-associated CD40 ligand transactivates B lymphocytes and promotes infection of CD4+ T cells.

Geneviève Martin1, Jocelyn Roy, Corinne Barat, Michel Ouellet, Caroline Gilbert, Michel J Tremblay.   

Abstract

Abnormal activation of B lymphocytes is a feature commonly seen in human immunodeficiency virus type 1 (HIV-1)-infected persons. However, the mechanism(s) responsible for this dysfunction is still poorly understood. Having recently shown that CD40L, the ligand for CD40, is inserted within emerging HIV-1 particles, we hypothesized that the contact between virus-anchored host CD40L and CD40 on the surface of B lymphocytes might result in the activation of this cell type. We report here that CD40L-bearing viruses, but not isogenic virions lacking host-derived CD40L, can induce immunoglobulin G and interleukin-6 production. Furthermore, such viral entities were found to induce B-cell homotypic adhesion. These effects were paralleled at the intracellular level by the nuclear translocation of the ubiquitous transcription factor NF-kappaB. The presence of host-derived CD40L within virions resulted in an increased virus attachment to B cells and a more-efficient B-cell-mediated transfer of HIV-1 to autologous CD4(+) T lymphocytes. All the above processes were independent of the virus-encoded envelope glycoproteins. Altogether, the data gathered from this series of investigations suggest that the incorporation of host-encoded CD40L in HIV-1 is likely to play a role in the B-cell abnormalities that are seen in infected individuals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17392362      PMCID: PMC1900293          DOI: 10.1128/JVI.02542-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  72 in total

Review 1.  Activators and target genes of Rel/NF-kappaB transcription factors.

Authors:  H L Pahl
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

2.  c-Rel is a selective activator of a novel IL-4/CD40 responsive element in the human Ig gamma4 germline promoter.

Authors:  Alessandra Agresti; Donata Vercelli
Journal:  Mol Immunol       Date:  2002-03       Impact factor: 4.407

3.  Molecular characterization of CD40 signaling intermediates.

Authors:  B G Werneburg; S J Zoog; T T Dang; M R Kehry; J J Crute
Journal:  J Biol Chem       Date:  2001-09-18       Impact factor: 5.157

Review 4.  IgE isotype determination: epsilon-germline gene transcription, DNA recombination and B-cell differentiation.

Authors:  H J Gould; R L Beavil; D Vercelli
Journal:  Br Med Bull       Date:  2000       Impact factor: 4.291

5.  CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs.

Authors:  S S Pullen; T T Dang; J J Crute; M R Kehry
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

6.  Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand, CD154.

Authors:  L E Haswell; M J Glennie; A Al-Shamkhani
Journal:  Eur J Immunol       Date:  2001-10       Impact factor: 5.532

7.  NF-kappaB activation for constitutive expression of VCAM-1 and ICAM-1 on B lymphocytes and plasma cells.

Authors:  Y F Xia; L P Liu; C P Zhong; J G Geng
Journal:  Biochem Biophys Res Commun       Date:  2001-12-14       Impact factor: 3.575

8.  HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals.

Authors:  S Moir; A Malaspina; K M Ogwaro; E T Donoghue; C W Hallahan; L A Ehler; S Liu; J Adelsberger; R Lapointe; P Hwu; M Baseler; J M Orenstein; T W Chun; J A Mican; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

9.  Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo.

Authors:  Salim Bounou; Jacques E Leclerc; Michel J Tremblay
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

10.  HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors.

Authors:  Bing He; Xugang Qiao; Per J Klasse; April Chiu; Amy Chadburn; Daniel M Knowles; John P Moore; Andrea Cerutti
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

View more
  27 in total

1.  Platelet decline as a predictor of brain injury in HIV infection.

Authors:  Ann B Ragin; Gypsyamber D'Souza; Sandra Reynolds; Eric Miller; Ned Sacktor; Ola A Selnes; Eileen Martin; Barbara R Visscher; James T Becker
Journal:  J Neurovirol       Date:  2011-09-29       Impact factor: 2.643

2.  Human immunodeficiency virus type-1 induces a regulatory B cell-like phenotype in vitro.

Authors:  Jacobo Lopez-Abente; Adrián Prieto-Sanchez; Maria-Ángeles Muñoz-Fernandez; Rafael Correa-Rocha; Marjorie Pion
Journal:  Cell Mol Immunol       Date:  2017-07-17       Impact factor: 11.530

3.  EBV LMP1, a viral mimic of CD40, activates dendritic cells and functions as a molecular adjuvant when incorporated into an HIV vaccine.

Authors:  Sachin Gupta; James M Termini; Liguo Niu; Saravana K Kanagavelu; Helena Schmidtmayerova; Victoria Snarsky; Richard S Kornbluth; Geoffrey W Stone
Journal:  J Leukoc Biol       Date:  2011-05-17       Impact factor: 4.962

4.  Immune Activation: Contribution to AIDS-Associated Non-Hodgkin Lymphoma.

Authors:  Marta Epeldegui; Otoniel Martínez-Maza
Journal:  For Immunopathol Dis Therap       Date:  2015

5.  Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection.

Authors:  M-A Jenabian; M Patel; I Kema; K Vyboh; C Kanagaratham; D Radzioch; P Thébault; R Lapointe; N Gilmore; P Ancuta; C Tremblay; J-P Routy
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

6.  Acquisition of host-derived CD40L by HIV-1 in vivo and its functional consequences in the B-cell compartment.

Authors:  Michaël Imbeault; Michel Ouellet; Katia Giguère; Jonathan Bertin; Dave Bélanger; Geneviève Martin; Michel J Tremblay
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

Review 7.  HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscape.

Authors:  Virginia Carroll; Alfredo Garzino-Demo
Journal:  Pathog Dis       Date:  2015-06-29       Impact factor: 3.166

8.  CD40 ligand (CD154) incorporated into HIV virions induces activation-induced cytidine deaminase (AID) expression in human B lymphocytes.

Authors:  Marta Epeldegui; Dharma R Thapa; Justin De la Cruz; Scott Kitchen; Jerome A Zack; Otoniel Martínez-Maza
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

9.  Immune surveillance and lymphoid malignancy in immunocompromised host.

Authors:  Patrick L Stevens; Nishitha M Reddy
Journal:  Am J Blood Res       Date:  2013-05-05

Review 10.  A lymphomagenic role for HIV beyond immune suppression?

Authors:  Riccardo Dolcetti; Annunziata Gloghini; Arnaldo Caruso; Antonino Carbone
Journal:  Blood       Date:  2016-01-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.